|
Construction Industry News Releases
|
Home | Submit Press Release | Advertise | Submit Website
(Construction.IndustryNews247.Com, October 04, 2018 ) Market Overview:
Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine presently available for prevention of tuberculosis (TB). In international locations with an excessive incidence of tuberculosis, one dose is recommended for healthful toddlers close to the time of birth. However, in areas in which tuberculosis is unusual, most effective kids at excessive danger are generally immunized, while suspected cases of tuberculosis are in my view tested and treated. Adults no longer inflamed with tuberculosis and who have no longer been formerly immunized but are frequently exposed to drug-resistant tuberculosis may be immunized as properly.
Request Report Sample: https://www.marketdataforecast.com/market-reports/bcg-vaccine-market-5199/request-sample
Increase in prevalence of tuberculosis across the world is main driver of the market
Factors affecting market growth:
Technological advancements (+) Intensifying healthcare expenditure (+) Increase in prevalence of tuberculosis across the world (+) Improved funding by government and other organizations (+) Rise in government initiatives (+) Global shortage of this vaccine (-) Side effects on usage of this vaccine (-) Get your customized report: https://www.marketdataforecast.com/market-reports/bcg-vaccine-market-5199/customize-report
North America accounted for the biggest market percentage
Market Segmentation
The Global BCG vaccine market is geographically segmented into
North America Europe Asia Pacific Latin America Middle East and Africa North America accounted for the biggest market percentage even as Asia Pacific is predicted to grow with the very best CAGR due to TB eradication campaigns occurring in the growing nations.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/bcg-vaccine-market-5199/
Key players:
Some of the main firms of the market include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institute.
Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|
|
|
Construction News by Sector
|
|
|
Industrial News TV
|